Skip to content
healthcare.dev

QUETIAPINE

NDC 33342-135, QUETIAPINE, tablet, extended release, from Macleods Pharmaceuticals Limited.

Product NDC
33342-135
Status
Listed
Labeler
Macleods Pharmaceuticals Limited
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA204253
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/33342-135 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • QUETIAPINE FUMARATE200 mg/1

Pharmacologic classes

Atypical Antipsychotic [EPC]

Package NDCNDC-11Package
33342-135-093334201350960 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-135-09)
33342-135-1533342013515500 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-135-15)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d699b8c7-8a1c-44ed-85d8-c821a9c8c848
  • NADAC price for package 33342013509

    GET /v1/drugs/nadac/33342013509

Use it

Look up 33342-135 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/33342-135 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 33342-135. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.